Skye Bioscience Income Statement (2012-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Shares Outstanding (Entity) (Quarter)	1.58M	1.90M	1.90M	1.98M	1.98M	1.98M	2.22M	3.89M	3.89M	7.88M	7.01M	28.06M	38.67M	38.82M	30.97M	39.65M	39.66M	39.67M	33.38M	35.13M
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	0.88M	0.33M	1.11M	1.27M	1.43M	1.78M	1.54M	1.18M	1.79M	1.25M	1.59M	1.95M	4.08M	4.88M	7.79M	7.20M	14.34M	9.36M	11.47M	7.94M
Wages, Salaries and Other (Quarter)
Selling, General & Administrative (Quarter)	0.95M	1.49M	1.35M	1.62M	1.79M	1.14M	1.54M	1.92M	1.21M	2.24M	2.49M	4.21M	4.33M	4.64M	4.55M	4.56M	3.91M	3.91M	3.43M	4.74M
Other Operating Expenses (Quarter)								-0.31M				1.15M		0.07M	0.14M		0.09M	0.09M	0.18M
Operating Expenses (Quarter)	1.83M	1.82M	2.46M	2.89M	3.22M	2.92M	9.28M	3.10M	2.84M	24.71M	4.09M	6.15M	8.41M	4.97M	10.67M	11.76M	18.24M	13.26M	14.90M	12.67M
Operating Income (Quarter)	-1.83M	-1.82M	-2.46M	-2.89M	-3.22M	-2.92M	-9.28M	-3.10M	-2.84M	-24.71M	-4.09M	-6.15M	-8.41M	-4.97M	-10.67M	-11.76M	-18.24M	-13.26M	-14.90M	-12.67M
EBIT (Quarter)	-1.83M	-1.82M	-2.46M	-2.89M	-3.22M	-2.92M	-9.28M	-3.10M	-2.84M	-24.71M	-4.09M	-6.15M	-8.41M	-4.97M	-10.67M	-11.76M	-18.24M	-13.26M	-14.90M	-12.67M
Non-operating items
Interest & Investment Income (Quarter)							0.02M	0.02M	0.01M	0.02M	0.05M	0.43M	0.96M	0.91M	0.73M	0.62M	0.53M	0.42M	0.27M	0.17M
Other Non Operating Income (Quarter)	0.12M	-0.19M	-0.15M	-0.04M	-0.01M	-0.01M	-323.00	-3.00				-0.00M	-359.00	-801.00		0.04M			-502.00	-0.00M
Non Operating Income (Quarter)	-0.19M	-0.01M	-0.05M	-0.16M	-0.20M	-0.21M	-0.61M	-2.07M	-0.26M	-0.24M	-0.33M	1.13M	0.51M	1.07M	0.92M	0.66M	0.62M	0.51M	0.45M	0.17M
Net income details
EBT (Quarter)	-2.02M	-1.82M	-2.51M	-3.04M	-3.41M	-3.13M	-9.89M	-5.17M	-3.11M	-24.95M	-4.42M	-5.02M	-7.89M	-3.90M	-9.75M	-11.10M	-17.62M	-12.75M	-14.44M	-12.51M
Tax Provisions (Quarter)	0.00M		500.00		0.01M		0.00M		0.00M			0.00M	0.01M			0.00M	0.00M
Profit After Tax (Quarter)	-2.02M	-1.82M	-2.51M	-3.04M	-3.42M	-3.13M	-9.89M	-5.17M	-3.11M	-24.95M	-4.42M	-5.02M	-7.90M	-3.90M	-9.75M	-11.10M	-17.62M	-12.75M	-14.44M	-12.51M
Income from Continuing Operations (Quarter)	-2.02M	-1.82M	-2.51M	-3.04M	-3.42M	-3.13M	-9.89M	-5.17M	-3.11M	-24.95M	-4.42M	-5.02M	-7.90M	-3.90M	-9.75M	-11.10M	-17.62M	-12.75M	-14.44M	-12.51M
Consolidated Net Income (Quarter)	-2.02M	-1.82M	-2.51M	-3.04M	-3.42M	-3.13M	-9.89M	-5.17M	-3.11M	-24.95M	-4.42M	-5.02M	-7.90M	-3.90M	-9.75M	-11.10M	-17.62M	-12.75M	-14.44M	-12.51M
Income towards Parent Company (Quarter)	-2.02M	-1.82M	-2.51M	-3.04M	-3.42M	-3.13M	-9.89M	-5.17M	-3.11M	-24.95M	-4.42M	-5.02M	-7.90M	-3.90M	-9.75M	-11.10M	-17.62M	-12.75M	-14.44M	-12.51M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-2.02M	-1.82M	-2.51M	-3.04M	-3.42M	-3.13M	-9.89M	-5.17M	-3.11M	-24.95M	-4.42M	-5.02M	-7.90M	-3.90M	-9.75M	-11.10M	-17.62M	-12.75M	-14.44M	-12.51M
Additional items
EPS (Basic) (Quarter)	-1.34	-1.10	-1.55	-1.53	-1.72	-1.58	-4.45	-1.37	-0.80	-3.17	-0.63	-0.18	-0.20	-0.10	-0.27	-0.28	-0.44	-0.32	-0.36	-0.32
EPS (Diluted) (Quarter)	-1.34	-1.10	-1.55	-1.53	-1.72	-1.58	-4.45	-1.37	-0.80	-3.17	-0.63	-0.18	-0.20	-0.10	-0.27	-0.28	-0.44	-0.32	-0.36	-0.32
Shares Outstanding (Quarter)	1.51M	1.65M	1.63M	1.98M	1.98M	1.98M	2.22M	3.77M	3.89M	7.88M	7.01M	28.00M	38.67M	38.82M	36.49M	39.65M	39.66M	39.67M	39.66M	39.68M
Shares Outstanding (Diluted) (Quarter)	1.51M	1.66M	1.63M	1.98M	1.98M	1.98M	2.22M	3.77M	3.89M	7.88M	7.01M	28.00M	38.67M	38.82M	36.49M	39.65M	39.66M	39.67M	39.66M	39.68M
EBITDA (Quarter)	-1.83M	-1.82M	-2.46M	-2.89M	-3.22M	-2.92M	-9.28M	-3.10M	-2.84M	-24.71M	-4.09M	-6.15M	-8.41M	-4.97M	-10.67M	-11.76M	-18.24M	-13.26M	-14.90M	-12.67M
Interest Expenses (Quarter)	0.19M	0.20M	0.20M	0.20M	0.21M	0.21M	0.66M	0.02M	0.19M	0.27M	-0.28M	5.68M	1.53M	-0.09M	-0.36M	0.00M	2.08M	1.74M		0.00M
Tax Rate (Quarter)	-0.08		-0.02		-0.15		-0.02		-0.12			-0.04	-0.10			-0.02	-0.02

Research Tools

Datasets

Plans

Developers

Skye Bioscience SKYE Income Statement (2012-2026)

Research Tools

Datasets

Plans

Developers

Skye Bioscience SKYE Income Statement (2012-2026)

Create an account

Sign In

Reset Password